PetMed Express, Inc. (PETS)

NASDAQ: PETS · IEX Real-Time Price · USD
4.790
-0.050 (-1.03%)
At close: Mar 28, 2024, 4:00 PM
4.870
+0.080 (1.67%)
After-hours: Mar 28, 2024, 6:32 PM EDT

Company Description

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.

The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses.

It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands.

The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PetMed Express, Inc.
PetMed Express logo
Country United States
Founded 1996
Industry Pharmaceutical Retailers
Sector Healthcare
Employees 302
CEO Mathew N. Hulett

Contact Details

Address:
420 South Congress Avenue
Delray Beach, Florida 33445
United States
Phone (561) 426-4444
Website 1800petmeds.com

Stock Details

Ticker Symbol PETS
Exchange NASDAQ
Fiscal Year April - March
Reporting Currency USD
CIK Code 0001040130
CUSIP Number 716382106
ISIN Number US7163821066
Employer ID 65-0680967
SIC Code 5912

Key Executives

Name Position
Mathew N. Hulett Chief Executive Officer, President and Director
Christine Chambers Chief Financial Officer, Principal Financial Officer, Principal Accounting Officer, Treasurer and Secretary
Mark Moseley Chief Technology and Information Officer
Daniel Job Pingree Chief Marketing Officer
Jacqueline Smith Vice President of People
Wendy Zalai Corporate Controller and Corporate Secretary

Latest SEC Filings

Date Type Title
Feb 15, 2024 8-K Current Report
Feb 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 13, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Feb 9, 2024 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Feb 8, 2024 8-K Current Report
Jan 25, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 8, 2024 8-K Current Report
Oct 31, 2023 10-Q Quarterly Report
Oct 30, 2023 8-K Current Report
Aug 30, 2023 S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments